BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Companion Animal Therapeutics Market: Increase in investments by government bodies is expected to drive the market

  Companion animals such as horses, cats, and dogs are increasingly playing an important part in the lives of several people. They provide friendship and a sense of responsibility, demand care and attention, and respond with love.

  March 23, 2021

   · 

  4 min read
• Growing Awareness about Food Allergy Driving Anaphylaxis Treatment: Fact.MR

  Investments towards promotion of fertility treatment services aimed towards international clients is likely to remain key to growth strategies in terms of sales in a fairly competitive industry.

  March 23, 2021

   · 

  6 min read
• IRRAS to Present at Redeye

  IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced that company management will present at the Swedish Investment Bank Redeye on March 30 at 4:00 pm-5:00pm CET.

  March 23, 2021

   · 

  1 min read
• Drug Development

  Phase 3 Trial Shows REGEN-COV™ (casirivimab with imdevimab) Antibody Cocktail Reduced Hospitalization or Death by 70% in Non-hospitalized COVID-19 Patients

  Companion dose-ranging Phase 2 trial showed significant and comparable viral reductions for all REGEN-COV doses tested, including as low as 300 mg

  March 23, 2021

   · 

  24 min read
• Ketorolac Market: Asia Pacific to Capture Major Share of Global Market

  Ketorolac is an anti-inflammatory drug that is used to treat short-term, moderate to severe pain. Ketorolac is prescribed before or after medical procedures such as surgery.

  March 23, 2021

   · 

  4 min read
• Genetown

  Zenas BioPharma Launches as a Cross-Border Biopharmaceutical Company to Bring Innovation to the Development and Delivery of Immune-Based Therapies

  Rapidly advancing seven pipeline programs, including three worldwide, with best-in-class potential in autoimmune and rare diseases

  March 23, 2021

   · 

  5 min read
• Dassault Systèmes Simulates Airflow in Paris Hospital to Reduce Risks of Exposure to COVID-19

  Dassault Systèmes is helping the Pitié-Salpêtrière AP-HP hospital in Paris evaluate airborne coronavirus infection risks in intensive care units, cafeterias and other areas

  March 23, 2021

   · 

  4 min read
• Genetown

  Biofidelity announces first peer reviewed publication of breakthrough ASPYRE™ technologyPublication validates the ability of ASPYRE to detect single copies of somatic variants in tissue and plasma

  Biofidelity Ltd, the cancer diagnostics company, announces that the first peer review article detailing its novel ASPYRE™ technology has been published in Scientific Reports, a Nature journal.

  March 23, 2021

   · 

  2 min read
• Policy

  Breakthrough Immunotherapy Earns First Regulatory Approval for Triple Negative Breast Cancer (TNBC)

  Immunopheresis™ therapy holds great promise for avoiding serious drawbacks of existing pharmaceuticals and improving patients’ quality of life

  March 23, 2021

   · 

  6 min read
• Biotech Beach

  Global WholeHealth Partners, Corp (OTC:GWHP) Secures Global Distribution Rights to Sell the AstraZeneca COVID-19 Vaccine Anywhere in the World Pending FDA Approval

  Global WholeHealth Partners Corp, (OTC PINK:GWHP) a multinational supplier of over 70+ FDA approved tests including Dengue, Ebola, Zika, Malaria also offering one of the largest lines of tests for CoViD19 SARS2, is prepared to help in the fight against CoViD19 SARS2.

  March 23, 2021

   · 

  6 min read